Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, read with Company’s Code of Conduct for Prevention of Insider Trading, Bafna Pharmaceuticals has informed that the ‘Trading Window’ for dealing in the Company’s Securities by the Designated Persons of the Company and their immediate relatives, will remain closed from October 01, 2024 till 48 hours after the declaration of Un-audited Financial Results for the Second Quarter ending September 30, 2024. Accordingly, all the Designated Persons of the Company and their immediate relatives have been intimated not to trade in the Company’s securities during the aforesaid period of closure of Trading Window.
The above information is a part of company’s filings submitted to BSE.
